Edgewise Therapeutics, Inc. Preferred Shares: Authorized and Outstanding
The company's filed XBRL preferred stock facts (us-gaap Preferred*), one row per period end, newest first. Values are as filed.
- 2026-06-30: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 200.00M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
- 2026-03-31: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 200.00M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-12-31: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 200.00M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-09-30: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 200.00M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
| Period end | Preferred Stock, Par or Stated Value Per Share | Preferred Stock, Shares Authorized | Preferred Stock, Shares Issued | Preferred Stock, Shares Outstanding | Preferred Stock, Dividend Rate, Percentage |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | 200.00M shares 10-Q · filed 2026-08-06 | 0.00 shares 10-Q · filed 2026-08-06 | 0.00 shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | 200.00M shares 10-Q · filed 2026-05-07 | 0.00 shares 10-Q · filed 2026-05-07 | 0.00 shares 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-06 | 200.00M shares 10-Q · filed 2026-08-06 | 0.00 shares 10-Q · filed 2026-08-06 | 0.00 shares 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | 200.00M shares 10-Q · filed 2025-11-06 | 0.00 shares 10-Q · filed 2025-11-06 | 0.00 shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | 200.00M shares 10-Q · filed 2025-08-07 | 0.00 shares 10-Q · filed 2025-08-07 | 0.00 shares 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | 200.00M shares 10-Q · filed 2025-05-08 | 0.00 shares 10-Q · filed 2025-05-08 | 0.00 shares 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 | 200.00M shares 10-K · filed 2026-02-26 | 0.00 shares 10-K · filed 2026-02-26 | 0.00 shares 10-K · filed 2026-02-26 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 | 200.00M shares 10-Q · filed 2024-11-07 | 0.00 shares 10-Q · filed 2024-11-07 | 0.00 shares 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 | 200.00M shares 10-Q · filed 2024-08-08 | 0.00 shares 10-Q · filed 2024-08-08 | 0.00 shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | 200.00M shares 10-Q · filed 2024-05-09 | 0.00 shares 10-Q · filed 2024-05-09 | 0.00 shares 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $0.00 10-K · filed 2025-03-03 | 200.00M shares 10-K · filed 2025-03-03 | 0.00 shares 10-K · filed 2025-03-03 | 0.00 shares 10-K · filed 2025-03-03 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | 200.00M shares 10-Q · filed 2023-11-09 | 0.00 shares 10-Q · filed 2023-11-09 | 0.00 shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-10 | 200.00M shares 10-Q · filed 2023-08-10 | 0.00 shares 10-Q · filed 2023-08-10 | 0.00 shares 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | 200.00M shares 10-Q · filed 2023-05-11 | 0.00 shares 10-Q · filed 2023-05-11 | 0.00 shares 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $0.00 10-K · filed 2024-02-22 | 200.00M shares 10-K · filed 2024-02-22 | 0.00 shares 10-K · filed 2024-02-22 | 0.00 shares 10-K · filed 2024-02-22 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-03 | 200.00M shares 10-Q · filed 2022-11-03 | 0.00 shares 10-Q · filed 2022-11-03 | 0.00 shares 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 | 200.00M shares 10-Q · filed 2022-08-04 | 0.00 shares 10-Q · filed 2022-08-04 | 0.00 shares 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-11 | 200.00M shares 10-Q · filed 2022-05-11 | 0.00 shares 10-Q · filed 2022-05-11 | 0.00 shares 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $0.00 10-K · filed 2023-02-23 | 200.00M shares 10-K · filed 2023-02-23 | 0.00 shares 10-K · filed 2023-02-23 | 0.00 shares 10-K · filed 2023-02-23 | 8.00% 10-K · filed 2022-02-24 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 | 200.00M shares 10-Q · filed 2021-11-10 | 0.00 shares 10-Q · filed 2021-11-10 | 0.00 shares 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 | 200.00M shares 10-Q · filed 2021-08-09 | 0.00 shares 10-Q · filed 2021-08-09 | 0.00 shares 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-13 | 200.00M shares 10-Q · filed 2021-05-13 | 0.00 shares 10-Q · filed 2021-05-13 | ||
| 2020-12-31 | $0.00 10-K · filed 2022-02-24 | 0.00 shares 10-K · filed 2022-02-24 | 0.00 shares 10-K · filed 2022-02-24 | 0.00 shares 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 |